Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Masked, 2-Arm Parallel Group Study Comparing the Effect of Brimonidine 0.2% Versus Timolol 0.5% on Visual Field Stability in Patients With Low-Pressure Glaucoma

NCT00317577 is registered in ClinicalTrials.gov with Chicago Center for Vision Research as lead sponsor.

NCT NCT00317577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00317577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Masked, 2-Arm Parallel Group Study Comparing the Effect of Brimonidine 0.2% Versus Timolol 0.5% on Visual Field Stability in Patients With Low-Pressure Glaucoma
Lead sponsor
Chicago Center for Vision Research
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1998
Completion date
May 31, 2004
Enrollment
160
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open angle